The BRILLIANT HIV Vaccine Consortium: Unfunded but not undone

2025/05/29 by Linda‐Gail Bekker, Glenda Gray · 1 voice
Social Sciences · Medicine · #Vaccine Coverage and Hesitancy #Hepatitis B Virus Studies #Viral Infections and Outbreaks Research

paper · pdf · doi:10.17159/sajs.2025/21985

openalex publication_date 2025/05/29 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Abstract

Whilst the global HIV epidemic can be brought under control through the deployment of antiretroviral-based treatment and prevention, elimination of HIV will require a safe, affordable and effective preventive vaccine.Africa bears the brunt of the HIV epidemic and can continue to play a significant and increasing role in the research and discovery of an African relevant HIV vaccine.

Discussions

• The BRILLIANT HIV Vaccine Consortium: Unfunded but not undone. doi.org/10.17159/saj... [bsky, 0 points, 0 comments]

Related

• The evolving epidemiology of HIV/AIDS
• R0 and the elimination of HIV in Africa: Will 90-90-90 be sufficient?
• A landscape analysis of the vaccine ecosystem in Africa: research and development funding, clinical trials, regulation, and manufacturing readiness
• Vaccine inequity: a threat to Africa’s recovery from COVID-19
• The Onchocerciasis Vaccine for Africa—TOVA—Initiative